CASI Pharmaceuticals Income Statement (2021-2025) | CASI

Income Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Dec2024 Mar2025 Jun2025
Revenue & cost
Revenue 9.03M8.55M10.21M10.26M8.35M9.82M8.84M6.87M3.41M3.98M6.24M4.17M
Cost of Revenue 3.28M3.40M3.57M5.59M3.38M4.82M2.52M2.53M1.60M4.42M2.62M4.96M
Gross Profit 5.30M5.02M5.97M10.99M4.97M5.83M5.19M4.06M1.81M2.07M3.62M2.06M
Operating items
Research & Development 3.99M3.85M3.90M-27.74M2.53M2.61M2.40M-17.41M-2.48M-1.25M-1.94M-1.72M
Selling, General & Administrative 5.33M5.52M4.85M-39.14M5.75M7.70M5.52M-44.35M-4.81M-5.94M-7.70M-6.08M
Other Operating Expenses 2.94M2.04M2.93M-29.78M3.90M4.86M2.37M-21.02M-3.97M-3.66M-4.36M-5.38M
Operating Expenses 12.26M11.41M11.68M-96.67M12.18M15.18M10.29M-82.78M-11.26M-10.86M-14.00M-13.18M
Operating Income -6.96M-6.39M-5.72M-14.97M-7.21M-9.35M-5.09M-3.43M-9.45M-8.79M-10.38M-11.12M
EBIT -6.96M-6.39M-5.72M-14.97M-7.21M-9.35M-5.09M-3.43M-9.45M-8.79M-10.38M-11.12M
Non-operating items
Interest & Investment Income -0.01M0.09M0.16M0.13M0.13M0.14M0.08M0.04M
Other Non Operating Income -0.33M-0.64M5.57M-0.06M-0.15M0.37M-0.23M0.27M-0.15M-0.41M
Non Operating Income 0.04M0.01M0.01M-0.02M1.34M0.01M0.47M-1.14M0.16M0.02M0.02M0.01M
Net income details
EBT -6.96M-6.39M-5.73M-14.88M-7.21M-9.35M-4.93M-3.30M-9.13M-8.46M-10.11M-10.84M
Tax Provisions 0.08M
Profit After Tax -8.40M-7.49M-5.02M61.17M-5.83M-10.07M-4.47M46.63M9.53M-6.96M-10.75M-13.38M
Equity Income -0.14M-0.17M-0.27M
Net Income - Minority -33.90M
Income from Non-Controlling Interests -0.42M-0.55M-0.74M-7.04M-0.67M-0.59M-0.60M-0.74M
Income from Continuing Operations -6.96M-6.39M-5.73M-14.88M-7.21M-9.43M-4.93M-3.30M-9.13M-8.46M-10.11M-10.84M
Consolidated Net Income -6.96M-6.39M-5.73M-14.88M-7.21M-9.43M-4.93M-3.30M-9.13M-8.46M-10.11M-10.84M
Income towards Parent Company -6.96M-6.39M-5.73M-48.78M-7.21M-9.43M-4.93M-3.30M-9.13M-8.46M-10.11M-10.84M
Net Income towards Common Stockholders -6.96M-6.39M-5.73M-48.78M-7.21M-9.43M-4.93M-3.30M-9.13M-8.46M-10.11M-10.84M
Additional items
EPS (Basic) -0.50-0.47-0.42-16.21-0.54-0.71-1.63-12.86-0.63-14.64-0.70
EPS (Weighted Average and Diluted) -0.25
Shares Outstanding (Weighted Average) 13.61M13.80M13.70M13.67M3.01M13.34M13.34M2.02M0.71M13.52M2.56M0.69M15.51M
Shares Outstanding (Diluted Average) 13.61M13.36M15.34M
EBITDA -8.15M-11.03M-8.15M72.11M-5.63M-12.25M-4.64M49.89M9.43M-7.28M-11.20M-13.39M
Interest Expenses -0.19M-0.19M-0.20M-0.24M
Tax Rate -0.86%